Abstract
BackgroundClaudin18.2 (CLDN18.2), a tight junction protein highly specific to gastric mucosa, is a promising target for gastric cancer (GC) treatment.1 Immunotherapy targeting PD-1 combined with chemotherapy has been approved as...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
